CareMax, Inc. reports unaudited Goodwill impairment for the three months ended September 30, 2023. For the three months, the company reported Goodwill impairment of $80,000,000.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.3 USD | +5.77% | +2.80% | -77.92% |
Apr. 01 | UBS Trims CareMax Price Target to $6.40 From $7, Maintains Neutral Rating | MT |
Mar. 18 | Transcript : CareMax, Inc., Q4 2023 Earnings Call, Mar 18, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-77.92% | 11.86M | |
-14.58% | 84.68B | |
+15.05% | 81.12B | |
+10.49% | 29.59B | |
-10.17% | 16.73B | |
-1.39% | 16.36B | |
-31.58% | 11.77B | |
+1.82% | 11.72B | |
+31.86% | 11.71B | |
-0.47% | 11.66B |
- Stock Market
- Equities
- CMAX Stock
- News CareMax, Inc.
- Caremax, Inc. Reports Unaudited Goodwill Impairment for the Three Months Ended September 30, 2023